<DOC>
	<DOC>NCT01423071</DOC>
	<brief_summary>The purpose of this study is to determine the prevalence of pulmonary hypertension (PH) among patients suffering from Chronic Obstructive Pulmonary Disease (COPD) and to assess the quality of life in those patients with concomitant PH compared to COPD patients without PH and those only suffering from pulmonary arterial hypertension (PAH) respectively.</brief_summary>
	<brief_title>Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: Prevalence and Quality of Life</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Hypertension, Pulmonary</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>Age â‰¥ 18 years Known or newly diagnosed COPD or PAH Written informed consent Present longterm oxygen treatment is no exclusion criterion Age &lt; 18 years Rightheart catheterization not reasonable Pregnancy, Lactation Life expectancy &lt;12 months due to any diseases aside from COPD Any medical, psychological or other condition, which limits the patient's ability to provide informed consent No written informed consent provided Current participation in another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Pulmonary Hypertension</keyword>
	<keyword>Chronic obstructive pulmonary disease</keyword>
	<keyword>Prevalence</keyword>
	<keyword>Quality of life</keyword>
</DOC>